Dr. Johann Brandes MD, PHD

Expert Publications

• Alteration of pemetrexed excretion in the presence of acute renal failure and effusions: presentation of a case and review of the literature.
• Occlusive endobronchial stent placement as a novel management approach to massive hemoptysis from lung cancer.
• Cancer DNA methylation: molecular mechanisms and clinical implications.
• Targeted therapy of non-small-cell lung carcinoma.
• CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC.
• Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer.
• Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer.
• Could valproic acid be an effective anticancer agent? The evidence so far.
• Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC.
• Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.
• Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer.

Media Releases

Get to know Oncologist Dr. Johann Brandes, who serves the population of Tennessee. Dr. Brandes is tri-certified and fellowship trained oncologist. He holds certification in Internal Medicine, Medical Oncology, and Critical Care Medicine by the American Board of Internal Medicine. Since its founding in 1936 to answer a public call to establish more uniform standards for physicians, Certification by the American Board of Internal Medicine (ABIM) has stood for the highest standard in internal medicine and its 20 subspecialties. Certification has meant that internists have demonstrated – to their peers and to the public – that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care. Dr. Brandes currently practices as an Oncologist with Tennessee Oncology, and is affiliated with St Thomas Hospital in Rutherford, Tennessee, where he holds an expertise in Thorasic Oncology. Tennessee Oncology, one of the nation’s largest, community-based cancer care specialists, is home to one of the leading clinical trial networks in the country. Established 1976 in Nashville, Tennessee Oncology’s mission remains unchanged: To provide access to high-quality cancer care and the expertise of clinical research for all patients, at convenient locations within their community and close to their home. Their growing network of physicians and locations is based on this mission. Dr. Brandes graduated with his Medical Degree from the University of Munich in Germany in 1998, giving him over two decades of experience in his field. After obtaining his Medical Degree he completed his residency with the Humboldt University Berlin in Germany. He then relocated to the United States and completed his internal medicine residency with the John Hopkins Hospital. Wanting to further his training he then completed his Medical Oncology and Pulmonary Disease and Critical Care Medicine Fellowship with the John Hopkins Hospital. To stay up to date in his field he remains a professional member of the American Society of Clinical Oncology and the American College of Chest Physicians and has been inducted as a Fellow of the American College of St Thomas. Oncology is a branch of medicine that deals with the diagnosis, treatment or prevention of cancer. The specialist who practices oncology is known as an oncologist. If an oncologist has special training in performing surgery on cancerous tumors, he or she is called a surgical oncologist. Dr. Brandes attributes his professional success to his hard work and diligence.

Recommended Articles

• Prostate Drugs May Not Increase the Risk of Fractures

  About 8 million men in the U.S. between the ages of 50-years-old and 79-years-old suffer from enlarged prostate glands. Drugs used to treat an enlarged prostate gland, also known as benign prostatic hyperplasia (BPH), are of two types: 5-alpha reductase inhibitors and alpha-blockers. In a study,...

• Expert Explains Latest Advances in Hodgkin Lymphoma, MCL

  Lymphoma is a cancer of the lymph nodes and lymphatic system. The two main types are Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL). The main difference between the two is in the specific lymphocyte each involves. ...

• Can Pap Smears Help to Detect Cervical Cancer?

  A study has confirmed that regular Pap tests can help to save a woman's life because it is able to detect cervical. Cancer diagnosed by Pap smeears were 92% curable, while those diagnosed by the symptoms alone were only 66% curable. Even women who had symptoms when they went for the regular...

• Cervical Cancer Defined

  The cervix connects the uterus and vagina. The endocervix is the part of the cervix that is closest to the uterus while an ectocervix is nearer to the vagina. Most cases of cervical cancer begin in the cell at the transformation zone. This zone is where the two main types of cells in the cervix...

• $5.8 Million Grant Given to Develop New Immunotherapy for Ovarian Cancer

  Ovarian cancer cells can be extremely tricky to get rid of, which makes treatment often expensive and prolonged. Researchers at the University of California San Diego recently received a 5.8-million-dollar grant from the state to develop a new form of immunotherapy for ovarian cancer.The StudyThe...

• Everything You Need to Know About Biopsy Procedures

  What is a biopsy?A biopsy is a medical procedure, which is mostly used in diagnosing cancer. In this procedure, a small tissue sample is taken from your body for a closer examination under the microscope. A biopsy is usually recommended by your doctor if initial tests in your body suggest an...